Dyne Therapeutics, Inc. ($DYN)
Friedl-Naderer Johanna โ Chief Commercial Officer
Shares
90,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 26, 2026
EPS:Est: -0.74
Transaction Details
| Insider | Friedl-Naderer Johanna |
|---|---|
| Title | Chief Commercial Officer |
| Transaction Date | Feb 12, 2026 |
| Expiration Date | Feb 11, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 17, 2026 |
| Document Date | Feb 12, 2026 |
| Shares Purchased | 90,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 90,000 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-055063 |
| Document | View SEC Filing |